Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Yates

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature Communications|December 5, 2023
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screeningAzucena Ramos, Catherine E Koch, Yunpeng Liu-Lupo, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Divergent phenotypic and functional roles of human T follicular helper cells from infancy to adulthoodSuhas Sureshchandra, Jenna M Kastenschmidt, Erika M Joloya, et al.
Developmental Cell|January 22, 2025
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
Developmental Cell|December 4, 2024
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencingHui Yu, Victor Wei Zhang, Asbjørg Stray-Pedersen, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature|September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myelomaNelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature Communications|December 5, 2023
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screeningAzucena Ramos, Catherine E Koch, Yunpeng Liu-Lupo, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Divergent phenotypic and functional roles of human T follicular helper cells from infancy to adulthoodSuhas Sureshchandra, Jenna M Kastenschmidt, Erika M Joloya, et al.
Developmental Cell|January 22, 2025
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
Developmental Cell|December 4, 2024
An orphan gene BOOSTER enhances photosynthetic efficiency and plant productivityBiruk A Feyissa, Elsa M de Becker, Coralie E Salesse-Smith, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2016
Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencingHui Yu, Victor Wei Zhang, Asbjørg Stray-Pedersen, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature|September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myelomaNelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Pageof 17